Table 2.
Characteristic | Result |
---|---|
Demographic characteristics | |
Age (years) | 24.3 [0.87–63.6] |
Sex (male) | 6 (75%) |
Rainy season | 6 (75%) |
Exposure risk | |
Reported contact with snails | 2 (25%) |
Previous mental disorders | 5 (63%) |
Clinical picture | |
Fever (>38 °C) | 5 (63%) |
Digestive signs and symptoms | 3 (38%) |
Neurological signs and symptoms | 8 (100%) |
Headaches | 2 (25%) |
Neck stiffness | 1 (13%) |
Dysfunction of cranial nerves | 3 (38%) |
Seizure | 2 (25%) |
Axial hypotonia, hemiparesia | 2 (25%) |
Radiculalgia | 1 (13%) |
Coma | 2 (25%) |
Brain imaging | |
Normal | 3 (38%) |
Enlargement of cerebral ventricles | 3 (38%) |
Cortical atrophy | 1 (13%) |
Laboratory results | |
In blood | |
C-reactive protein > 5 mg/L | 2 (25%) |
Total WBC count (G/L) | 10.0 [6.61–20.75] |
Blood eosinophilia at admission (G/L) | 1.72 [0.49–6.43] |
Blood eosinophilia at admission (% of WBC) | 12.5 [5–31] |
Max blood eosinophilia during hospitalisation (G/L) | 2.99 [0.89–6.43] |
Max blood eosinophilia during hospitalisation (% of WBC) | 23.5 [10–36] |
A. cantonensis positive serodiagnosis | 7 (88%) |
In CSF | |
Eosinophilia in CSF at first LP (/mm3) | 74.5 [0–1550] |
Eosinophilia in CSF at first LP (% of WBC) | 25.0 [0–68] |
CSF glucose at first LP (mmol/L) | 2.81 [0.1–4.3] |
Protein level in CSF at first LP (g/L) | 1.14 [0.33–1.71] |
Protein level > 0.45 g/L at first LP | 7 (88%) |
Presence of antibodies in CSF (among those tested) | 6 (100%) |
Management | |
Length of hospital stay (days) | 27 [15–66] |
Subtractive LP | 5 (63%) |
Corticosteroids | 5 (63%) |
Anthelmintic therapy | 7 (88%) |
Outcome | |
One year recovery | 2 (25%) |
One year neurological sequelae | 5 (63%) |
One year mortality | 1 (13%) |
Abbreviations: CSF, cerebrospinal fluid; LP, lumbar puncture; WBC, white blood cell.
Descriptive results are presented as n (%) and as median (min–max).